Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin’s Lymphoma June 3, 2019
Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies May 31, 2019
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer May 30, 2019
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award May 29, 2019
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S. May 20, 2019
Akrevia Therapeutics Appoints Distinguished Research Leaders to Scientific Advisory Board May 16, 2019